89bio Inc [ETNB] stock is trading at $7.13, up 3.03%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ETNB shares have gain 16.98% over the last week, with a monthly amount drifted -10.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, RBC Capital Mkts downgraded its rating to Sector Perform on January 12, 2024, and dropped its price target to $15. On October 10, 2023, downgrade downgraded it’s rating to Perform. UBS started tracking the stock assigning a Buy rating and suggested a price target of $36 on August 28, 2023. Evercore ISI initiated its recommendation with a Outperform and recommended $49 as its price target on June 13, 2023. Raymond James upgraded its rating to Strong Buy for this stock on May 12, 2022, and downed its price target to $12. In a note dated December 20, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $46 on this stock.
89bio Inc [ETNB] stock has fluctuated between $5.99 and $16.63 over the past year. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. 89bio Inc [NASDAQ: ETNB] shares were valued at $7.13 at the most recent close of the market. An investor can expect a potential return of 68.3% based on the average ETNB price forecast.
Analyzing the ETNB fundamentals
Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -1298.53%, Pretax Profit Margin comes in at -1216.49%, and Net Profit Margin reading is -1234.87%. To continue investigating profitability, this company’s Return on Assets is posted at -0.63, Equity is -0.6 and Total Capital is -0.72. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.95 points at the first support level, and at 6.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.26, and for the 2nd resistance point, it is at 7.39.
Ratios To Look Out For
For context, 89bio Inc’s Current Ratio is 11.65. In addition, the Quick Ratio stands at 11.65 and the Cash Ratio stands at 2.34.
Transactions by insiders
Recent insider trading involved McWherter Charles, Director, that happened on Jan 22 ’25 when 10000.0 shares were purchased. Director, McWherter Charles completed a deal on Jan 21 ’25 to buy 5000.0 shares. Meanwhile, Le-Nguyen Quoc sold 10963.0 shares on Jan 15 ’25.
